A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial on the Efficacy and Safety of PanhematinTM in the Treatment of Acute Attacks of Porphyria

    Project: Other project

    Project Details

    StatusFinished
    Effective start/end date11/12/13 → 8/31/21

    Funding

    • Recordati Rare Diseases Inc: $168,677.70